Childhood Cancer Incidence, New York State Excl New York City, 2015-2019
Source: New York State Cancer Registry
| Site of Cancer | Ages 0-4 | Ages 5-9 | Ages 10-14 | Ages 15-19 | Combined Ages 0-14 | Combined Ages 0-19 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avg Annual Cases | Rate per 1,000,000 | Avg Annual Cases | Rate per 1,000,000 | Avg Annual Cases | Rate per 1,000,000 | Avg Annual Cases | Rate per 1,000,000 | Avg Annual Cases | Rate per 1,000,000 | 95% CI | Avg Annual Cases | Rate per 1,000,000 | 95% CI | |
| All Invasive Malignant Tumors | 150.4 | 246.4 | 82.2 | 128.5 | 123.2 | 182.8 | 211.2 | 280.2 | 355.8 | 185.1 | 176.6-193.9 | 567.0 | 209.0 | 201.3-216.8 |
| I Leukemias, myeloproliferative and myelodysplastic diseases | 46.2 | 75.7 | 22.0 | 34.4 | 23.2 | 34.4 | 28.8 | 38.2 | 91.4 | 47.6 | 43.4-52.2 | 120.2 | 45.3 | 41.7-49.0 |
| I(a) Lymphoid leukemias | 36.6 | 60.0 | 17.6 | 27.5 | 13.8 | 20.5 | 11.4 | 15.1 | 68.0 | 35.5 | 31.8-39.4 | 79.4 | 30.3 | 27.4-33.5 |
| I(b) Acute myeloid leukemia | 7.8 | 12.8 | 2.4 | 3.8 | 6.4 | 9.5 | 9.6 | 12.7 | 16.6 | 8.6 | 6.9-10.7 | 26.2 | 9.7 | 8.1-11.5 |
| II Lymphomas and reticuloendothelial neoplasms | 10.6 | 17.4 | 11.4 | 17.8 | 22.8 | 33.8 | 48.2 | 63.9 | 44.8 | 23.1 | 20.2-26.4 | 93.0 | 33.4 | 30.4-36.6 |
| II(a) Hodgkin lymphoma | 0.4 | 0.7 | 1.4 | 2.2 | 10.8 | 16.0 | 32.2 | 42.7 | 12.6 | 6.4 | 4.9-8.2 | 44.8 | 15.5 | 13.6-17.7 |
| II(b,c,d) Non-Hodgkin lymphomas | 10.2 | 16.7 | 10.0 | 15.6 | 12.0 | 17.8 | 15.8 | 21.0 | 32.2 | 16.7 | 14.2-19.5 | 48.0 | 17.8 | 15.6-20.2 |
| III CNS & misc intracranial & intraspinal neoplasms | 32.8 | 53.7 | 26.4 | 41.3 | 24.6 | 36.5 | 16.6 | 22.0 | 83.8 | 43.7 | 39.6-48.0 | 100.4 | 38.2 | 34.9-41.7 |
| III(a) Ependymomas and choroid plexus tumor | 3.2 | 5.2 | 2.0 | 3.1 | 1.4 | 2.1 | 1.8 | 2.4 | 6.6 | 3.5 | 2.4-4.9 | 8.4 | 3.2 | 2.3-4.3 |
| III(b) Astrocytoma | 18.2 | 29.8 | 15.2 | 23.8 | 14.8 | 22.0 | 9.4 | 12.5 | 48.2 | 25.1 | 22.0-28.5 | 57.6 | 21.9 | 19.4-24.6 |
| III(c) Intracranial and intraspinal embryonal tumors | 7.4 | 12.1 | 3.6 | 5.6 | 2.6 | 3.9 | 1.2 | 1.6 | 13.6 | 7.1 | 5.5-9.0 | 14.8 | 5.7 | 4.5-7.2 |
| III(d) Other gliomas | 2.8 | 4.6 | 5.4 | 8.4 | 5.0 | 7.4 | 3.8 | 5.0 | 13.2 | 6.8 | 5.3-8.7 | 17.0 | 6.4 | 5.1-7.9 |
| IV Neuroblastoma and other peripheral nervous cell tumors | 20.6 | 33.7 | 3.0 | 4.7 | 0.6 | 0.9 | 0.6 | 0.8 | 24.2 | 12.9 | 10.7-15.4 | 24.8 | 9.8 | 8.2-11.7 |
| IV(a) Neuroblastoma and ganglioneuroblastoma | 20.6 | 33.7 | 3.0 | 4.7 | 0.4 | 0.6 | 0.4 | 0.5 | 24.0 | 12.8 | 10.6-15.2 | 24.4 | 9.7 | 8.0-11.6 |
| V Retinoblastoma | 6.6 | 10.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.3 | 6.6 | 3.5 | 2.4-5.0 | 6.8 | 2.7 | 1.9-3.8 |
| VI Renal tumors | 13.6 | 22.3 | 4.0 | 6.3 | 1.4 | 2.1 | 1.0 | 1.3 | 19.0 | 10.0 | 8.1-12.2 | 20.0 | 7.8 | 6.4-9.5 |
| VI(a) Nephroblastoma and other nonepithelial renal tumor | 13.6 | 22.3 | 3.8 | 5.9 | 0.4 | 0.6 | 0.0 | 0.0 | 17.8 | 9.4 | 7.5-11.5 | 17.8 | 7.0 | 5.6-8.6 |
| VII Hepatic tumors | 4.2 | 6.9 | 0.4 | 0.6 | 0.8 | 1.2 | 1.4 | 1.9 | 5.4 | 2.8 | 1.9-4.1 | 6.8 | 2.6 | 1.8-3.6 |
| VII(a) Hepatoblastoma and mesenchymal tumors of liver | 3.8 | 6.2 | 0.4 | 0.6 | 0.4 | 0.6 | 0.0 | 0.0 | 4.6 | 2.4 | 1.5-3.6 | 4.6 | 1.8 | 1.2-2.7 |
| VIII Malignant bone tumors | 0.8 | 1.3 | 3.0 | 4.7 | 12.4 | 18.4 | 14.6 | 19.4 | 16.2 | 8.3 | 6.6-10.3 | 30.8 | 11.1 | 9.4-13.0 |
| VIII(a) Osteosarcoma | 0.2 | 0.3 | 0.8 | 1.3 | 7.6 | 11.3 | 7.4 | 9.8 | 8.6 | 4.4 | 3.2-5.9 | 16.0 | 5.7 | 4.5-7.1 |
| VIII(c) Ewing tumor and related sarcomas of bone | 0.6 | 1.0 | 2.2 | 3.4 | 4.0 | 5.9 | 4.4 | 5.8 | 6.8 | 3.5 | 2.4-4.9 | 11.2 | 4.1 | 3.1-5.3 |
| IX Soft tissue and other extraosseous sarcomas | 7.8 | 12.8 | 5.6 | 8.8 | 8.2 | 12.2 | 14.4 | 19.1 | 21.6 | 11.2 | 9.2-13.6 | 36.0 | 13.2 | 11.3-15.3 |
| IX(a) Rhabdomyosarcoma | 5.2 | 8.5 | 2.6 | 4.1 | 3.0 | 4.5 | 4.8 | 6.4 | 10.8 | 5.6 | 4.2-7.3 | 15.6 | 5.8 | 4.6-7.3 |
| X Germ cell & trophoblastic tumors & gonadal neoplasms | 3.6 | 5.9 | 2.4 | 3.8 | 4.8 | 7.1 | 20.2 | 26.8 | 10.8 | 5.6 | 4.2-7.3 | 31.0 | 10.9 | 9.3-12.8 |
| X(a) Intracranial and intraspinal germ cell tumor | 0.4 | 0.7 | 0.6 | 0.9 | 2.2 | 3.3 | 2.2 | 2.9 | 3.2 | 1.6 | 0.9-2.7 | 5.4 | 2.0 | 1.3-2.9 |
| X(c) Malignant gonadal germ cell tumor | 0.4 | 0.7 | 1.6 | 2.5 | 2.6 | 3.9 | 15.8 | 21.0 | 4.6 | 2.4 | 1.5-3.6 | 20.4 | 7.0 | 5.7-8.6 |
| XI Other malignant epithelial neoplasms and malignant melanomas | 1.6 | 2.6 | 3.6 | 5.6 | 23.4 | 34.7 | 63.2 | 83.8 | 28.6 | 14.6 | 12.3-17.1 | 91.8 | 32.0 | 29.1-35.1 |
| XI(b) Thyroid carcinoma | 0.4 | 0.7 | 0.6 | 0.9 | 10.4 | 15.4 | 38.4 | 50.9 | 11.4 | 5.8 | 4.4-7.5 | 49.8 | 17.1 | 15.1-19.4 |
| XI(d) Malignant melanoma | 1.0 | 1.6 | 1.0 | 1.6 | 2.0 | 3.0 | 5.4 | 7.2 | 4.0 | 2.1 | 1.3-3.2 | 9.4 | 3.4 | 2.5-4.5 |
| XII Other and unspecified malignant neoplasms | 2.0 | 3.3 | 0.4 | 0.6 | 0.8 | 1.2 | 2.0 | 2.7 | 3.2 | 1.7 | 1.0-2.7 | 5.2 | 1.9 | 1.3-2.8 |
Notes
- Incidence data are provisional, November 2021.
- Rates are per 1,000,000 children. Rates for 0-14 and 0-19 year age intervals are age-adjusted within these intervals to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases per year are unstable and should be used with caution.
- Non-Hodgkin lymphomas, Burkitt, and miscellaneous lymphomas are grouped together under II(b,c,d).
